Unlock instant, AI-driven research and patent intelligence for your innovation.

Double-stranded RNA compound AUK and application thereof in vaccine preparation

A compound and vaccine technology, applied in the direction of antisense single-stranded RNA virus, vaccine, veterinary vaccine, etc., can solve the problems of limited application, toxic side effects, unstable chemical structure, etc.

Pending Publication Date: 2021-09-28
BEIJING ACADEMY OF AGRICULTURE & FORESTRY SCIENCES
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, Poly I:C-induced cytokine storm has caused severe toxic side effects in some cancer treatment patients, including shock, renal failure, coagulation disorders, and hypersensitivity reactions, thus limiting the clinical application of Poly I:C
The chemical structure of Poly I:C is unstable, and it is easily degraded by body fluids containing RNase enzymes. Its half-life is only a few minutes, and it cannot effectively activate the immune system when used in low doses, which further limits its application in vaccine adjuvants

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Double-stranded RNA compound AUK and application thereof in vaccine preparation
  • Double-stranded RNA compound AUK and application thereof in vaccine preparation
  • Double-stranded RNA compound AUK and application thereof in vaccine preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0061] Embodiment 1. Preparation of complex AUK

[0062]Weigh Poly A 0.1132g, add it to 49ml PBS (10mM, pH7.2), dissolve it as Poly A stock solution; weigh Poly U 0.1152g, add it into 49ml PBS (10mM, pH7.2), dissolve it as Poly U stock solution; prepare 80mg / ml kanamycin sulfate stock solution with PBS (10mM, pH7.2). Heat the prepared Poly A stock solution, Poly U stock solution, and Kanamycin Sulfate stock solution in a water bath to 50°C, and mix the three stock solutions to make the Poly A: Poly U: Kanamycin Sulfate stock solution in the mixture The liquid volume ratio is 0.49:0.49:0.02, and each 1ml of the preparation obtained contains Poly A (1.02mg), Poly U (0.98mg), and kanamycin sulfate (1.6mg). The mixture was incubated in a water bath at 50°C for 30 minutes, then incubated at 0°C for 1 hour, and finally filtered and sterilized using a 0.22 μm sterile filter to obtain the complex, which was named AUK. The concentration of the obtained AUK solution was 2 mg / ml (kanam...

Embodiment 2

[0063] Example 2. Property detection of complex AUK

[0064] 1. Molecular weight detection

[0065] The molecular weight of the compounds was analyzed using 1.5% agarose gel electrophoresis. RNA loading buffer (Thermo Fisher), DL2000 molecular marker (DL2000 Marker) (0.2-2KB, Takara) was used to estimate the sample size distribution range. The results of agarose gel electrophoresis figure 1 As shown, 1 is Poly I:C solution (2mg / ml), 2 is Poly A:U solution (2mg / ml), 3 is AUK solution (2mg / ml). The length distribution of complex AUK is between 500-1200bp, and the molecular weight range is between 340-816KDa. The length and molecular weight of Poly A:U and Poly I:C are close to AUK.

[0066] 2. Ultraviolet absorption spectrum detection

[0067] Microplate reader (Biotek Synergy TM H1) Scan the spectrum of the complex AUK in the range of 230nm-300nm to detect its ultraviolet absorption spectrum. The result is as figure 2 As shown, the UV absorption peak of the complex AUK...

Embodiment 3

[0094] Example 3. Vaccine Preparation and Immunization

[0095] 1. Preparation of virus liquid

[0096] H9N2 virus was used as antigen to evaluate the effect of complex AUK in chicken immunization experiments. Prepare the H9N2 virus solution as follows:

[0097] (1) Get the H9N2 subtype avian influenza virus and make appropriate dilution (such as 10 h) with sterilized saline -4 or 10 -5 diluted), inoculate 0.1ml into the allantoic cavity of each embryo, seal the pinhole, and continue to incubate at 36-37°C without turning the eggs.

[0098] (2) Within 48 hours after inoculation, the eggs were illuminated once a day, and the chicken embryos that died within 48 hours were discarded. After that, take photos every 4 to 6 hours, and take out the dead chicken embryos at any time until 96 hours. After 96 hours, regardless of whether the chicken embryos are dead or not, all the chicken embryos are taken out, the air chamber is upright, and cooled at 2-8°C for 4-24 hours.

[0099] ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Poison priceaaaaaaaaaa
Login to View More

Abstract

The invention relates to vaccine preparation, in particular to a double-stranded RNA compound AUK and application thereof in vaccine preparation. The double-stranded RNA (Ribonucleic Acid) compound provided by the invention is prepared from 0.5 to 20 mg / ml of Poly A, 0.5 to 20 mg / ml of Poly U and 0.2 to 80 mg / ml of kanamycin. The compound can effectively activate an immune system of chickens and enhance the immune efficacy of antigens, and is expected to be used as a poultry specific TLR3 agonist for preparing vaccine adjuvants.

Description

technical field [0001] The invention relates to vaccine preparation, in particular to a double-stranded RNA complex AUK and its application in vaccine preparation. Background technique [0002] In 1925, French immunologist Gaston Ramon discovered that adding certain substances unrelated to the active ingredients of the vaccine could specifically enhance the body's immune response to the corresponding pathogen. The substance that can enhance the body's specific immune response to the antigen is called an adjuvant or an immunopotentiator when the animal is immunized prior to or mixed with the antigen. Excellent adjuvants and immune enhancers can significantly improve the immune activity of traditional vaccines and genetically engineered vaccines, reduce vaccination costs, and improve vaccine response levels. Adjuvants can increase the efficiency of antigen presentation by activating the innate immune response, so the use of adjuvants to improve vaccine efficacy is an economic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/39A61K39/145A61P31/16
CPCA61K39/39A61K39/12A61P31/16C12N2760/16034A61K2039/55561A61K2039/55511A61K2039/552A61K2039/5252
Inventor 郭芳芳徐福洲曹晓亚章振华史爱华崔一芳
Owner BEIJING ACADEMY OF AGRICULTURE & FORESTRY SCIENCES